iRhythm Holdings, Inc. (IRTC) analyst actions

IRTC analyst actions moved a median of -0.31% by the close. Rating and price-target actions on IRTC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IRTC overview →

14 measured IRTC analyst action events.

Where these IRTC analyst actions landedvs 14 measured IRTC analyst action reactions
IRTC analyst actionMiddle 50% · -0.84% to +0.72%Zero: 0.00%Median: -0.31%Median -0.31%-1.50%0+1.50%
Middle 50% of IRTC analyst action reactions-0.84% to +0.72%
Median reaction (to close)-0.31%
Measured reactions14
Point-in-time · zero look-ahead

Half of the 14 IRTC analyst action events with a measured close landed between -0.84% and +0.72%; 36% closed up.

DateHeadlineEvent5-minTo close
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release+0.19%-0.44%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release+0.03%-0.19%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release-0.19%+0.60%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release-0.83%-0.11%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release-0.07%+2.38%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release-0.96%-2.27%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release+0.26%+1.55%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release-0.04%-0.94%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release-0.13%-0.46%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release+0.37%-0.53%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release-0.40%+0.75%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach OutPress release-3.50%-2.96%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release+0.90%-1.27%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach OutPress release-2.28%+4.50%
That’s how IRTC usually reacts to analyst actions — get an email when it moves on news →
Keep exploring

More IRTC: earnings → · SEC filings → · IRTC overview →

Other Healthcare names and their analyst actions

TickerEventsMedian 30-min% positive
Neovasc Inc. - Common Shares (NVCN)1,136-0.47%37%
Iovance Biotherapeutics, Inc. (IOVA)1,135+0.11%51%
GENOMIC HEALTH (GHDX)1,1110.00%49%
INDIVIOR PLC S/ADR (INVVY)1,1050.00%33%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.